OsteoBiologics, Alphatec in spine pact:
This article was originally published in Clinica
Executive Summary
Carlsbad, California-based spinal implant device and surgical instrument developer Alphatec Spine has secured exclusive US distribution rights to certain spine products manufactured from OsteoBiologics' PolyGraft material. The products will be for use in bone void filling applications in the spine, specifically in the cervical and lumbar regions. The agreement is expected to open up a significant market for OsteoBiologics' Polygraft, as the spine represents the most significant market opportunity for bone void filling products, claims the San Antonio, Texas company. Polygraft is a polymeric, resorbable material that acts as a scaffold while the natural tissue heals.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.